Epa and Dha Have Selective Toxicity for Pbmcs From Multiple Myeloma Patients in a Partly Caspase-Dependent Manner Publisher Pubmed



Mortaz E^{1, 2, 3} ; Moloudizargari M⁴ ; Khosravi A⁵ ; Asghari MH^{6, 7} ; Movassaghi M³ ; Varahram M¹¹ ; Vaezi M^{8, 9} ; Redegeld FA² ; Garssen J^{2, 10} Show Affiliations
Source: Clinical Nutrition Published:2020

Abstract

Poly-unsaturated fatty acids (PUFAs) have been shown to have cytotoxic effects in both solid and non-solid tumors. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are among the most studied PUFAs. The aim of the present study was to evaluate the cytotoxic effects of these two fatty acids (FAs) in the peripheral blood mononuclear cells (PBMCs) obtained from untreated patients (new cases) with confirmed symptomatic multiple myeloma (MM). Our results showed that EPA at the concentration of 100 μM and DHA at 50 and 100 μM induce potent apoptotic effects in the PBMCs of MM patients (P < 0.05) as evidenced by Annexin V and propidium iodide (PI) staining, while they have little or no effects on the PBMCs isolated from healthy donors (P > 0.05). The observed effects were concentration- and time-dependent and 72 h treatment with DHA at a concentration of 100 μM had the strongest effect (P < 0.01). CD138 + cells isolated from MM patients showed great sensitivity to EPA/DHA. EPA- and DHA-induced apoptosis was significantly inhibited by the pan-caspase inhibitor (Z-VAD-FMK), indicating that cell death was at least partly dependent on caspase activation. The results of the present study showed that EPA and DHA have selective toxicities for malignant human plasma cells from MM patients, but not for mononuclear cells of healthy donors. These results warrant further studies with larger study populations to investigate the usefulness of PUFAs as a promising adjunctive therapy in the treatment of MM. © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism